This RSA section is an unofficial mirror, is not legal advice, and may be incomplete, outdated, or incorrectly processed.

RSA 126-X:10 · Annual Data Report; Release of Data

Title: X: PUBLIC HEALTH
Chapter: 126-X · USE OF CANNABIS FOR THERAPEUTIC PURPOSES
Status: current
Official source linked: Yes

Official source Copy section link

126-X:10 Annual Data Report; Release of Data. –

Copy link

The commissioner of the department of health and human services shall report annually on the therapeutic use of cannabis program established under this chapter to the health and human services oversight committee established under RSA 126-A:13, to the board of medicine, and to the board of nursing.

Copy link

II.

The report shall be in electronic format to allow for identification of patterns of certification by patient and caregiver, location, age, medical condition, symptom, or side effect, and provider, and for analysis and research to inform future policy, educational, and clinical decisions.

Copy link

III.

The initial report shall be filed no later than December 1, 2014.

Copy link

IV.

The commissioner's data report shall include but not be limited to the following information:

Copy link

(a)

The number of designated caregivers and the number of qualifying patients, by town or city and county.

Copy link

(b)

The ages of the qualifying patients and the ages of the designated caregivers.

Copy link

(c)

The qualifying medical conditions and the number of each qualifying medical condition.

Copy link

(d)

The symptoms or side effects and the number of each symptom or side effect.

Copy link

(e)

The number of physicians and the number of advanced practice registered nurses issuing written certifications.

Copy link

(f)

The number of providers in each medical specialty issuing written certifications.

Copy link

(g)

Any other issues related to the therapeutic use of cannabis permitted under this chapter that the health and human services oversight committee shall request.

Copy link

A summary of the report submitted by alternative treatment centers as required under RSA 126-X:8, XII.

Copy link

VI.

Notwithstanding any other provision of law, data collected under this chapter, including de-identified or aggregate data contained in the confidential registry database, may be released, with the approval of the commissioner or designee, to individuals or entities for the purposes of public health, health care operations, or research if such release is consistent with all applicable HIPAA standards. Source. 2013, 242:1, eff. July 23, 2013. 2019, 85:1, 2, eff. Aug. 17, 2019.

Copy link

Source note

Source. 2013, 242:1, eff. July 23, 2013. 2019, 85:1, 2, eff. Aug. 17, 2019.

Source history

2013, 242:1, eff. July 23, 2013
2019, 85:1, 2, eff. Aug. 17, 2019

Related materials

Bill relationships

2026 HB1235 reference
or if the gift of cannabis is contingent upon a separate transaction for goods or services; or (c) Possessing or purchasing cannabis paraphernalia. III. Except as provided in RSA 126-X, any person under 21 years of age who knowingly possesses 3/4 ounce or less of cannabis, including adulterants or dilutants, shall be guilty of a violation, and subject to the penalties provided in paragraph V. IV. Exc
2026 HB1235-FN reference
or if the gift of cannabis is contingent upon a separate transaction for goods or services; or (c) Possessing or purchasing cannabis paraphernalia. III. Except as provided in RSA 126-X, any person under 21 years of age who knowingly possesses 3/4 ounce or less of cannabis, including adulterants or dilutants, shall be guilty of a violation, and subject to the penalties provided in paragraph V. IV. Exc
2026 HB1446 amend
ely on the basis of their lawful participation in this program. 2 New Section; Therapeutic Use of Cannabis Protections; Right to Purchase, Possess, and Transfer Firearms. Amend RSA 126-X by inserting after section 2 the following new section: 126-X:2-a Firearm Rights of Qualifying Patients. I. A qualifying patient, caregiver, or other person lawfully registered under this chapter shall not be deni
2026 HB1796 reference · effective 2027-01-01
PTER 126-XX THERAPEUTIC USE OF PSILOCYBIN 126-XX:1 Definitions. In this chapter: I. "Board" means the psilocybin production establishment licensing board created pursuant to RSA 126-XX:7. II. "Provider" means an approved medical or therapy provider licensed in this state who also holds a license from the department to recommend or provide services to qualified patients. III. "Department" means th
2026 HB1796-FN reference · effective 2027-01-01
PTER 126-XX THERAPEUTIC USE OF PSILOCYBIN 126-XX:1 Definitions. In this chapter: I. "Board" means the psilocybin production establishment licensing board created pursuant to RSA 126-XX:7. II. "Provider" means an approved medical or therapy provider licensed in this state who also holds a license from the department to recommend or provide services to qualified patients. III. "Department" means th
2026 HB186 reference
es to obtain a therapeutic cannabis endorsement that would allow them to serve qualifying patients without imposing the proposed excise tax. The bill would allow Alternative Treatment Centers, registered under RSA 126-X as not-for-profit entities, to convert to for-profit entities or operate as either for profit or not-for -profit. The bill includes a General Fund appropriation to the Department for the biennium ending June 3
2026 HB186-FN-A reference
of age or older, but not for resale. "Consumer" does not include a qualifying patient or designated caregiver purchasing cannabis from an alternative treatment center pursuant to RSA 126-X. XV. "Department" means the department of health and human services. XVI. “Designated caregiver” means “designated caregiver” as defined in RSA 126-X:1, VI. XVII. "Documentation" means all records, in any form, in
2026 HB54 amend
es; Approvals of Statutory Conversion. ?Amend RSA 304-C:149 by inserting after paragraph VIII the following new paragraph: IX. ?In the case of the conversion of an alternative treatment center registered under RSA 126-X and organized pursuant to RSA 292, such conversion shall be approved by the board of directors in accordance with RSA 126-X:8, XX. 9 Effective Date. This act shall take effect 60 days after its passage. LBA 25
2026 HB54-FN reference
nd powers vested in the merging corporations, including any powers previously conferred upon them by the legislature. II. ? An alternative treatment center registered pursuant to RSA 126-X and organized under this chapter may, pursuant to RSA 126-X:8, XX, convert to either a domestic corporation organized under RSA 293-A or a limited liability company organized under to RSA 304-C, and may merge with a dom
2026 SB468 reference
ed by RSA 126-X:8, XII, the impacts of greenhouse cultivation on energy costs and product prices. The department shall include this information in its annual report required under RSA 126-X:10, V. 2 ?Effective Date. ?This act shall take effect upon passage. HELPFUL LINKS Redistricting Information Ethics Committee Statutory/Study Committees Voting Records Past Member Legislation Driving Directions IT Help D
2026 SB479 reference
nd powers vested in the merging corporations, including any powers previously conferred upon them by the legislature. II. ? An alternative treatment center registered pursuant to RSA 126-X and organized under this chapter may, pursuant to RSA 126-X:8, XX, convert to either a domestic corporation organized under RSA 293-A or a limited liability company organized under to RSA 304-C, and may merge with a dom
2026 SB479-FN reference
nd powers vested in the merging corporations, including any powers previously conferred upon them by the legislature. II. ? An alternative treatment center registered pursuant to RSA 126-X and organized under this chapter may, pursuant to RSA 126-X:8, XX, convert to either a domestic corporation organized under RSA 293-A or a limited liability company organized under to RSA 304-C, and may merge with a dom